The epidemiology of biliary tract cancers has changed in the United States in the past several decades. The aim of this study is to evaluate biliary tract cancers with regard to the incidence rates, etiology, treatment, and survival in Olmsted County between 1976 and 2008.
INTRODUCTION
Biliary tract cancers, the malignancies involving the biliary drainage system, include cholangiocarcinoma (CCA), ampulla of Vater cancer, and gall bladder (GB) cancer ( 1 ) . Although it is relatively rare in the United States, the prognosis of patients with biliary cancers is extremely poor as they are usually detected at an advanced stage.
Th e epidemiology of biliary tract cancers has changed in the world including United States over the past three decades. Population-based data from the Surveillance Epidemiology and End Results (SEER) program showed an increase in the incidence and mortality rates of intrahepatic cholangiocarcinoma (ICC) in the United States ( 2 -4 ) . Similar trends were also observed in the United Kingdom between 1971 and 2001. In this population, there was a 12-fold increase in the incidence rate of ICC, but a markedly decrease in the incidence of GB and extrahepatic cholangiocarcinoma (ECC) ( 5 ) . Consistent with this trend, there was a global trend of an increasing mortality from ICC and decreasing mortality from ECC ( 6, 7 ) . However, in contrast, a nation-wide population-based study from Denmark showed a decreasing trend in both ICC and ECC incidence rates ( 8 ) .
In the past two decades, improvements have been made in the treatment of patients with biliary cancers. Innovative interventions, such as liver transplantation following intensive neoadjuvant therapy, have been shown to improve survival if applied in early stages of ECC ( 9 ) . Further, loco-regional treatment modalities such as Biliary Tract Cancers in Olmsted County, Minnesota, 1976 Minnesota, -2008 radiofrequency ablation, endoscopic / radiographic brachytherapy and systemic chemotherapy may benefi t patients with intermediate and advanced stage biliary cancers ( 10 -12 ) . It is unclear, however, whether these new modalities have had any impact on patient outcomes at the population level.
To address these questions, we conducted a population-based study to describe trends in the incidence rates, management, and survival in biliary cancer patients residing in Olmsted County, Minnesota, United States between 1976 and 2008.
METHODS

Database
Epidemiologic research in Olmsted County, Minnesota is possible because the county is relatively isolated from other urban centers and nearly all medical care is delivered to patients in the population by a handful of health-care providers. Since 1966, the majority of the health-care providers in the community have shared their medical records for research purposes under the auspices of the Rochester Epidemiology Project (REP; R01 AG034676). Currently, the participants in the REP include the Mayo Clinic and its two affi liated hospitals, Olmsted Medical Center and its affi liated hospital, and the Rochester Family Medicine Clinic, the single private practitioner in the County. Together, these providers provide 90 -96 % of all health care to Olmsted County residents ( 13 ) . Th e result is the linkage of medical records from essentially all sources of medical care available to and utilized by the Olmsted County population.
Th e health-care providers who participate in the REP use a unit (or dossier) medical record system whereby all data collected on an individual are assembled in on place ( 14 ) . Th ese records contain the details of every inpatient hospitalization, every outpatient visit to the offi ces, clinics, or emergency rooms in the county, every physician visit to nursing homes or private homes, as well as all laboratory results, pathology reports (including autopsies), and correspondence concerning each patient. Th e medical details are collected by physicians for the delivery of subspecialty level medical care and are of high quality. Additionally, the median duration of medical records is substantial. Virtually everyone in Olmsted County is seen at least once at one of the health-care providers in the county within a 3-year period. Between 1999 and 2001, 131,879 patients aged 18 years and older were seen at an REP provider, representing nearly 100 % of the Olmsted County residents in that age range ( 13, 15 ) . Th e median number of years encompassed by the combined medical records for Olmsted County residents 18 and older ranged from 12 to 57 years. Th erefore, the median years of follow-up available for Olmsted County residents are typically quite high.
Study population
All Olmsted County residents aged over 20 with a newly diagnosed biliary tract cancers between 1976 and 2008 were identifi ed using the REP ( 13, 15 ) . To identify all potential biliary tract cancer patients, Hospital International Classifi cation of Disease Adaptation codes and ICD (International Statistical Classifi cation of Diseases and Related Health Problems)-9 were used. Supplementary Table 1 online lists all of the codes used to identify potential study subjects. Only local residents who lived within Olmsted County for at least 1 year before cancer diagnosis were included. Th is was to prevent inclusion of patients who might have moved into Olmsted County for the management of liver disease or biliary tract cancers.
Biliary tract cancers were classifi ed into fi ve disease categories based on the anatomic location of tumor. Th ese include ICC, Perihilar CCA, common bile duct CCA, ampulla of Vater cancer, and GB cancer. We defi ned ICC as a tumor arising from the small intrahepatic bile ductules as a mass-forming lesion in the liver parenchyma beyond the secondary biliary radicals. Perihilar CCA was defi ned as tumor involving the common hepatic duct, bifurcation of hepatic duct and large intrahepatic duct (up to the secondary biliary radicals). Diagnosis of biliary tract cancer was made by histology (73 % ) or characteristics radiographic features (CT or MRI scans or Endoscopic Retrograde Cholangiopancreatography) with (19 % ) or without (8 % ) cytology. Characteristics radiographic fi ndings include a tumor arising from the biliary tract or a malignant-appearing biliary stricture with progressive tumor mass on cross-sectional images without evidence of metastasis into biliary tract from other primary sources including the gastrointestinal tract or pancreas ( 16 ) . Th is study was approved by the Institutional Review Board of Mayo Clinic and Olmsted County Medical Center.
Clinical information
Relevant clinical information was abstracted from medical records. Th ese data included risk factors for biliary tract cancers, co-morbidities, tumor staging, primary treatment modality, survival status, and cause of death. For tumor staging, pathologic TNM (tumor, node, metastasis) staging were abstracted if surgical TNM staging was available. If not, clinical TNM staging was recorded based on the cross-sectional images obtained at the time of cancer diagnosis.
Treatment was classifi ed into three groups. Th e fi rst group included patients who had surgical resection of tumors or liver transplantation. Th e second group included patients who had systemic or radiation treatment of tumors without surgery. Th e third group included patients who only had received comfort care.
Vital status of study subjects was assessed as of 1 December 2010. Medical records were reviewed to determine the date of death and identify the cause of death. Th e cause of death was divided into two categories. A cancer-related death was designated if the patient died of a complication from progressing biliary tract cancer as the main or a contributing condition. Other decedents were classifi ed as cancer-unrelated deaths.
As a part of investigation to understand the changes in biliary tract cancer incidence rates, we considered utilization of cholecystectomy in Olmsted County. All 
Statistical analysis
Th e R ( http://www.r-project.org/ ) and SAS (SAS Institute, Cary, NC) packages were used for statistical analyses. In calculating incidence rates in the community, the entire population of Olmsted County (age ≥ 20) was considered to be at risk. Agespecifi c person-years were estimated from decennial census data with linear interpolation between census years. With the assumption that incident cases follow a Poisson distribution, 95 % confidence intervals for incidence rate were calculated. Incidence rate was adjusted to the population structure of the United States in 2000. Trend for incidence rates was tested by fi tting a Poisson regression model where cancer counts was the outcome and age, sex, and era were independent predictors. Th e model was adjusted for the population size of each era.
Patient survival was assessed from the time of cancer diagnosis to the last known follow-up or death. In patients who have not died or were lost to follow-up, the observation was censored on the day of last follow-up. Survival probabilities were estimated using the Kaplan -Meier method and compared by the log-rank test.
RESULTS
Patient characteristics
Initially, 216 subjects with a diagnosis of biliary tract cancers were identifi ed in the REP database. Upon review of the records, 77 patients were excluded because patients did not have primary biliary tract cancers: these include pancreatic cancer ( n = 27), cancer of other known primary ( n = 22), cancer of unknown origin ( n = 5), hepatocellular carcinoma ( n = 2), and other benign diagnoses ( n = 21). Eighteen patients were excluded because the 1-year residency requirement was not met and fi ve patients were excluded because cancer diagnosis was made before 1976. Th e remaining 116 patients were included in this analysis. Table 1 summarizes the baseline characteristics of patients in this study. Th e mean age of our cohort was 71 years and half were male. Th ere was a female preponderance in patients with GB cancers and most patients were white. A quarter of patients with ICC and a smaller proportion of patients with perihilar CCA (14 % ) also had evidence of cirrhosis. PSC was present only in a small subset of patients with perihilar CCA (7 % ). Only 2 % had family history of biliary tract cancers in a fi rst degree relative. As expected, the majority of patients with GB cancers had a history of gall stone disease while only 5 % had porcelain GB. No patients in our cohort had evidence of chronic viral hepatitis, hepatolithiasis, biliary tract anomaly, or parasite infection. Table 2 shows the temporal trends in age-adjusted incidence rates for biliary tract cancers in Olmsted County between 1976 and 2008. Th e overall age-sex-adjusted incidence rate of ICC increased from 0.3 to 2.1 per 100,000 person-years between 1976 and 2008 ( P = 0.02). On the other hand, the overall age-sex-adjusted incidence rate of GB cancer decreased from 4.0 to 2.2 per 100,000 
Incidence rates of biliary cancers
Risk factors
Alcohol 2 (13 % ) 3 (11 % ) 1 (6 % ) 1 (7 % ) 3 (7 % ) 10 (9 % ) 0.94 
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person-years between 1976 and 2008 ( P = 0.04). Th e increase in the incidence of ICC was predominantly seen in men, whereas the decrease in the incidence of GB cancer was mainly in women. Th e overall incidence rates of biliary tract cancers showed no signifi cant change over time ( P = 0.81).
A sensitivity analysis was performed aft er excluding patients without histologic or cytologic confi rmation of diagnosis. Th e change in the incidence rates of ICC remained signifi cant. However, it was no longer signifi cant in GB cancers: in the fi rst (1976 -1990) , second (1991 -2000) , and third (2001 -2008) era, the overall age-sex-adjusted incidence rate of ICC was 0.3 (95 % CI, 0 -0.8), 0.8 (95 % CI, 0 -1.5), and 2.0 (95 % CI, 0.7 -3.3) per 100,000 person-years ( P = 0.03). On the other hand, the overall agesex-adjusted incidence rate of GB cancer was 3.7 (95 % CI, 2.1 -5.3), 2.1 (95 % CI, 0.8 -3.3), and 2.2 (95 % CI, 0.8 -3.5) per 100,000 person-years ( P = 0.09).
As there were signifi cant changes in the incidence rate of ICC and GB cancer, we investigated the potential underlying cause of this trend. We fi rst examined the proportion of patients with cirrhosis among ICC patients as cirrhosis has been proposed as a risk factor for ICC. Neither of the two ICC patients in the fi rst era (0 % ) had cirrhosis, whereas one out of the four ICC patients in the second era (25 % ), and three out of ten in the third era (30 % ) had evidence of cirrhosis. Next, in relation to the decreased incidence of GB cancer, we calculated the incidence rates of cholecystectomy in the Olmsted County community. Th e age-and sex-adjusted incidence rate of cholecystectomy in Olmsted County increased over the study period. Th is increasing trend was statistically signifi cant in women ( Table 3 ) .
Clinical management and outcome of biliary cancers
Initial tumor staging, treatment approaches, and patient survival in individual cancers are described in Table 4 . Overall, 59 % of patients had TNM stage 3 or 4 biliary tract cancers at initial presentation. While the majority of patients with GB cancer (90 % ) had stage 3 or 4 disease, only 23 % of patients with common bile duct or ampulla of Vater cancer had stage 3 or 4 disease. Consequently, patients with common bile duct or ampulla of Vater cancer were more likely to receive surgical treatment.
As a result of a high proportion of tumors detected at an advanced stage, the overall median survival in patients with biliary tract cancer was only 6.3 months, with a 5-year survival of mere 6 -14 % . Over time, there was minimal improvement in the overall survival (4.2 -7.7 months between 1976 and 2008; Figure 1 ). Aft er adjusting for the location of tumors, this change in the overall survival was marginally signifi cant ( P = 0.07). Patients who received curative surgical treatment had better survival -their median survival was 50 months whereas that for those who did not undergo curative resection had was only 3.8 months ( P < 0.01). Th is trend was observed in each subtype of cancers ( Supplementary Table 2 ).
With regard to the cause of death, while most patients died of their biliary tract cancer, a third of patients with ampulla of Vater cancer died of causes other than the cancer. When only cancerrelated death was considered, survival in patients with ampulla of Vater cancer was longer, with median survival of 23, compared with 6.0 months in patients with other subtypes ( P < 0.05).
DISCUSSION
In this population-based study investigating the trend in the incidence rate of biliary tract cancers in Olmsted County, the incidence of ICC has increased and the incidence of GB cancer has decreased over the past three decades. When these malignancies were grouped together, the overall incidence did not change. Th e majority of patients presented with advanced stage cancers, leading to a poor overall survival, although there was a trend for better survival in more recent patients.
Several studies to date have shown that the incidence of ICC has increased in the United States ( 2 -4 ). Th ese studies were performed using the SEER data. Patel ( 2 ) fi rst described the increasing incidence of ICC in the United States (ICD-9-CM 1976 -1990 ( n =46) 
-
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point to the possibility that an increasing number of ICC patients harbor cirrhosis in the background. Although the majority of our patients did not have viral hepatitis or cirrhosis, our data are congruent with other investigators who have suggested that chronic liver disease and cirrhosis constitute an important risk factor for ICC ( 17 ) . Similarly to ICC, studies investigating the incidence of GB cancers were performed using the SEER data. Carriaga and Henson ( 18 ) fi rst reported that the incidences of GB cancer had slightly decreased from 1.4 to 1.2 per 100,000 person-years between 1973 and 1987. More recent studies also confi rmed the decreasing incidence of GB cancer between 1973 and 2002 ( 19, 20 ) . Th us, the decreasing incidence rates of GB cancer in Olmsted County are confi rmatory to the previously reported national trend. However, the absolute rate of GB cancer incidence (2.2 -4.0 per 100,000 person-years) was much higher in Olmsted County than the incidence rates reported based on the SEER data (1.1 -1.8 per 100,000 person-years). Exclusion of GB cancers that were not histologically confi rmed in previous studies might have, in part, underestimated the incidence of GB cancers ( 18 ) .
Our data showed that the reduction of GB cancer incidence in Olmsted County was mainly driven by the trend in women while it did not change materially in men. While this needs further confi rmation in another population, the reciprocal increase in the utilization rate of cholecystectomy during the same period suggests that the removal of diseased GBs may in fact reduce the number at risk for GB cancer. Th ere have been other studies that suggested that adoption of laparoscopic cholecystectomy may have contributed to the trend ( 21, 22 ) . Clearly, however, one should not (Clinical Modifi cation) code = 155.1). Age-specifi c incidence rates of ICC increased from 0.1 per 100,000 in 1973 to 0.7 per 100,000 person-years in 1997. A second study using the same data (ICD-O = 8160, 8162, 8260, 8481, 8500, 8560) reported that the incidence of ICC increased from 0.3 to 0.9 per 100,000 personyear between 1975 and 1999 ( 3 ). In that study, 7 % of ICC cases were " Klatskin " tumors, which were misclassifi ed as ICCs. In another study by Welzel et al . ( 4 ), Klatskin tumors were reclassifi ed as ECCs but the rise in the incidence persisted (0.3 -0.8 per 100,000 person-year between 1973 and 2001). Despite methodological diff erences, these studies consistently documented a rise in the incidence rates of ICC consistently, which were similar to the incidence rates generated in this study. Further, our data extend the observation that the incidence of ICC continued to increase even aft er 2000.
Th e reason for the increasing incidence of ICC remains to be completely understood. Although small in number, our data 
The Biliary Tract Cancers in Olmsted County construe these data to indicate that prophylactic cholecystectomy in an asymptomatic patient with gall stones may be warranted from the standpoint of reducing the future risk of GB cancer as only small portion of patient develop GB cancer and risk and cost related to surgery does not does not exceed the potential benefi t ( 23, 24 ) . Long-term survival was extremely low in patients with biliary tract cancers although there was a trend of improvement in 1-year and 5-year survival over the past three decades in Olmsted County. Trend in the overall survival aft er the diagnosis of biliary tract cancers was previously reported in SEER studies. For example, the 1-year survival for ICCs slightly improved from 16 % to 28 % between 1975 and 1999 ( 3 ) . Similarly, the median survival in patients with GB cancer increased from 4 to 6 months between 1973 and 2002 ( 19 ) . We believe that survival improvement in patients with biliary tract cancer is in part attributed to advances in surgical technique as well as improvement in nonsurgical modalities, such as chemotherapy and radiation treatment ( 25 ) . Despite these increase in survival in patients with ICC and GB cancers, the overall survival of all bile duct cancers has not changed with a 5-year survival of 10 % between 1979 and 2004 ( 20 ) . Consistent with national statistics, our results suggest that survival of patients with biliary tract cancer remained very poor despite minimal improvement over the past three decades. Consistent with previous study, our data showed that the prognosis of patients with Ampulla of Vater cancer is better than in patients with other subtypes of biliary tract cancer ( 18 ) . Th e cancer detection at an earlier stage, thus higher proportion of patient receiving surgical treatment may explains this better survival in patients with Ampulla of Vater.
Th ere are several weaknesses in our study. First, data from Olmsted County may not be generalizable to the entire United States in terms of racial / ethnic distribution, disease patterns, and access to care. Individuals of Caucasian race, known to have lower incidence of biliary tract cancers, are overrepresented in Olmsted County ( 20 ) , which will tend to underestimate the true incidence rates of biliary tract cancers in the United States. In terms of the access to care, although local patients had better access to specialized care (e.g., Mayo Clinic) than most communities, the poor survival result in this study indicates that it provided no real advantage. Second, our study is based on a relatively small number of cases due to the small size of the local population. Th erefore, we refrained from performing detailed trend analyses within each subset of biliary tract cancers. Th is limitation in the sample size must be gauged against the advantages of the study setting in Olmsted County where we were able to identify all biliary cancer patients, to accurately enumerate the denominator population, and to access medical records in the community. Th is last point is a substantial strength of this study, as studies based on diagnostic codes may fail to accurately discern the location of the tumor -a third of CCA in the SEER database does not have a location specifi ed ( 20 ) .
In summary, the incidence of ICC in Olmsted County increased and the incidence of GB cancer decreased over the past three decades. Th e overall incidence rate of biliary tract cancer has not changed. Although there was minimal improvement in survival, prognosis of patients with biliary tract cancers remains extremely poor. To the extent that these epidemiologic trends have been reproducible, urgent eff orts are needed to elucidate reasons for these observations.
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